China Resources Jiangzhong raises stake in Jiangzhong Pharmaceutical to 43.13%

China Resources Jiangzhong Pharmaceutical Group Co., Ltd. and its concerted parties have increased their combined stake in Jiangzhong Pharmaceutical to 43.13% from 42.84%. This equity change, which crosses the 1% threshold, stems from an ongoing shareholding increase plan initiated on October 22, 2024.

Since the disclosure of the share increase plan, China Resources Jiangzhong has cumulatively acquired 2,784,350 shares through centralized bidding, representing approximately 0.44% of the company's total share capital, with a total investment of CNY 60,002,129.20. Specifically, between July 1, 2025, and September 17, 2025, an additional 1,845,500 shares were acquired, increasing their stake by approximately 0.29%.

The capital for these acquisitions originates from both proprietary funds and bank loans, with Industrial and Commercial Bank of China Nanchang Donghu Branch providing up to CNY 84 million in credit. This equity change does not alter the company's controlling shareholder or actual controller.